• Search
  • Login
  • Register
Menu
  • BJMO
  • Home
  • News
  • CongressUpdate
  • Specials
  • Links
All
  • All
  • BJMO articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Pharma News

Category

Pharma News
  • Clinical Practice
  • Science
  • Cancer trials
  • Editor's pick
  • Health Innovation
  • Prevention
  • Pharma News

Pharma News

Osimertinib plus chemotherapy prolongs PFS in EGFR-mutated NSCLC patients

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • The prognostic significance of disseminated tumour cells in bone marrow in patients with operable breast cancer: An updated analysis
  • Burnout in resident physicians
  • Simply the B(r)east: Endothelial cell heterogeneity in health and disease
  • Highlights of the ASCO Gastrointestinal Cancers Symposium 2023
  • Journal Scan
  • New oncology reimbursements in Belgium
  • Introducing the new BSMO President (2023–2026): Interview with Prof. E. de Azambuja
Pharma News

Novel therapy for ESR1-mutated advanced or metastatic breast cancer approved by FDA

Read more
Pharma News

Pembrolizumab plus chemotherapy delays disease progression in endometrial carcinoma

Read more
Pharma News

NALIRIFOX regimen improves OS and PFS in patients with metastatic PDAC

Read more
Pharma News

FDA approves first gene therapy for patients with high-risk bladder cancer

Read more
Pharma News

ADDING ABEMACICLIB TO FIRST LINE ENDOCRINE THERAPY RESULTS IN A CLINICALLY RELEVANT SURVIVAL B...

Read more
Pharma News

FDA approval to tremelimumab plus durvalumab with chemotherapy for NSCLC patients

Read more
Pharma News

FDA grants Orphan drug designation to KIR-CAR T cell therapy for mesothelioma patients

Read more
Pharma News

Chemotherapy drug crizotinib usage extended to children with ALCL or IMT

Read more
1 2 3 4 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJMO
  • Ads & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJMO is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJMO 2023